Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis

Clinics in Liver Disease

Volumn 12, Issue 2, 2008, Pages 323-331

  Hirschfield, Gideon M ^a   Heathcote, E J ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PATHOGENESIS; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; REVIEW;

AUTOANTIBODIES; HUMANS; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA;

EID: 43049086319     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2008.02.003     Document Type: Review

References (48)

1. Ahrens Jr. E.H., Payne M.A., Kunkel H.G., et al. Primary biliary cirrhosis. Medicine (Baltimore) 29 4 (1950) 299-364
2. Walker J.G., Doniach D., Roitt I.M., et al. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1 (1965) 827-831
3. Jones D.E. Pathogenesis of primary biliary cirrhosis. Gut 56 11 (2007) 1615-1624
4. Gershwin M.E., and Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47 (2008) 737-745
5. Goudie R.B., Macsween R.N., and Goldberg D.M. Serological and histological diagnosis of primary biliary cirrhosis. J Clin Pathol 19 6 (1966) 527-538
6. Hadziyannis S., Scheuer P.J., Feizi T., et al. Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol 23 2 (1970) 95-98
7. Geubel A.P., Baggenstoss A.H., and Summerskill W.H. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome. Gastroenterology 71 3 (1976) 444-449
8. Brunner G., and Klinge O. A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis). Dtsch Med Wochenschr 112 38 (1987) 1454-1458 [in German]
9. Ben-Ari Z., Dhillon A.P., and Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 18 1 (1993) 10-15
10. Michieletti P., Wanless I.R., Katz A., et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 35 2 (1994) 260-265
11. Taylor S.L., Dean P.J., and Riely C.A. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 18 1 (1994) 91-99
12. Lacerda M.A., Ludwig J., Dickson E.R., et al. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 90 2 (1995) 247-249
13. Goodman Z.D., McNally P.R., Davis D.R., et al. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 40 6 (1995) 1232-1242
14. Sanchez-Pobre P., Castellano G., Colina F., et al. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?. J Clin Gastroenterol 23 3 (1996) 191-198
15. Invernizzi P., Crosignani A., Battezzati P.M., et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 25 5 (1997) 1090-1095
16. Kinoshita H., Omagari K., Whittingham S., et al. Autoimmune cholangitis and primary biliary cirrhosis-an autoimmune enigma. Liver 19 2 (1999) 122-128
17. Czaja A.J., Carpenter H.A., Santrach P.J., et al. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31 6 (2000) 1231-1238
18. Zhang F.K., Jia J.D., and Wang B.E. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int 3 2 (2004) 288-291
19. Kadokawa Y., Omagari K., Ohba K., et al. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?. Liver Int 25 2 (2005) 317-324
20. Heathcote J. Autoimmune cholangitis. Gut 40 4 (1997) 440-442
21. Heathcote E.J. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31 4 (2000) 1005-1013
22. Kaplan M.M., and Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 353 12 (2005) 1261-1273
23. Oertelt S., Rieger R., Selmi C., et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45 3 (2007) 659-665
24. Miyakawa H., Tanaka A., Kikuchi K., et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 34 2 (2001) 243-248
25. Ludwig J. The pathology of primary biliary cirrhosis and autoimmune cholangitis. Baillieres Best Pract Res Clin Gastroenterol 14 4 (2000) 601-613
26. Kaserer K., Exner M., Mosberger I., et al. Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunhistochemical study. Virchows Arch 432 3 (1998) 217-222
27. Watanabe S., Deguchi A., Uchida N., et al. Histopathologic comparison of anti-mitochondrial antibody-positive primary biliary cirrhosis and autoimmune cholangiopathy. Hepatol Res 19 1 (2001) 41-51
28. O'Donohue J., Wong T., Portmann B., et al. Immunohistochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis. Eur J Gastroenterol Hepatol 14 10 (2002) 1143-1150
29. Tsuneyama K., Van De Water J., Van Thiel D., et al. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Hepatology 22 5 (1995) 1440-1446
30. Ikuno N., Scealy M., Davies J.M., et al. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display. Hepatology 34 3 (2001) 478-486
31. Hoso M., Nakanuma Y., Kawano M., et al. Granulomatous cholangitis in chronic hepatitis C: a new diagnostic problem in liver pathology. Pathol Int 46 4 (1996) 301-305
32. Rubio-Tapia A., and Murray J.A. The liver in celiac disease. Hepatology 46 5 (2007) 1650-1658
33. Ishak K.G. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc 73 5 (1998) 467-472
34. Wee A., and Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?. Ann Intern Med 102 5 (1985) 581-587
35. Umemura T., Zen Y., Hamano H., et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 46 2 (2007) 463-471
36. Vergani D., and Bogdanos D.P. Positive markers in AMA-negative PBC. Am J Gastroenterol 98 2 (2003) 241-243
37. Muratori P., Muratori L., Ferrari R., et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 98 2 (2003) 431-437
38. Rigopoulou E.I., Davies E.T., Pares A., et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54 4 (2005) 528-532
39. Zuchner D., Sternsdorf T., Szostecki C., et al. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 26 5 (1997) 1123-1130
40. Bandin O., Courvalin J.C., Poupon R., et al. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 23 5 (1996) 1020-1024
41. Nakamura M., Kondo H., Mori T., et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45 1 (2007) 118-127
42. Sakauchi F., Mori M., Zeniya M., et al. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 16 1 (2006) 30-34
43. Stone J., Wade J.A., Cauch-Dudek K., et al. Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis. J Hepatol 36 1 (2002) 8-13
44. Juran B.D., Atkinson E.J., Schlicht E.M., et al. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology 47 2 (2008) 280-287
45. Lan R.Y., Cheng C., Lian Z.X., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43 4 (2006) 729-737
46. Liu B., Shi X.H., Zhang F.C., et al. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. Liver Int 28 (2008) 233-239
47. Kim W.R., Poterucha J.J., Jorgensen R.A., et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology 26 1 (1997) 22-26
48. Gisbert J.P., Jones E.A., Pajares J.M., et al. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?. Aliment Pharmacol Ther 17 1 (2003) 17-27